We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZIONP:NASDAQZions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer Analysis

Data as of 2026-05-12 - not real-time

$19.12

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Valuation appears deeply attractive: the stock trades at a trailing P/E of 3.1 versus an industry average of 16.5, and a price‑to‑book of 0.40 while delivering a dividend yield of 6.44%. Cash on hand (~$4 bn) comfortably exceeds debt (~$3 bn), and revenue grew 10.2% YoY, supporting the recent earnings beat of $1.56 EPS in Q1 2026. Technical signals are mixed: the price sits just above the identified support at $18.99 and below resistance at $19.49, RSI is neutral at 46, and a bullish MACD histogram (+0.0096) contrasts with an overall bearish trend and decreasing volume. Risk profile is modest: beta is low at 0.21 and 30‑day volatility is under 10%, but regional‑bank sector and regulatory exposure remain medium‑level concerns.
Given the strong dividend, low valuation multiples, solid cash position, and modest short‑term technical downside, the stock is positioned for a potential rebound toward the $19.5 resistance, while the high dividend yield adds income appeal. Investors should monitor volume trends and any shifts in interest‑rate expectations that could affect regional banks, but the current fundamentals suggest a favorable risk‑adjusted return horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near immediate support at $18.99
  • Decreasing trading volume
  • Neutral RSI and bearish trend direction

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Low P/E and P/B relative to peers
  • Strong cash position and low debt
  • High dividend yield supporting total return

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained earnings growth and revenue expansion
  • Defensive regional‑bank exposure with low beta
  • Attractive dividend income and undervalued valuation multiples

Key Metrics & Analysis

Financial Health

Revenue Growth10.20%
Profit Margin28.36%
P/E Ratio3.1
ROE14.12%
ROA1.09%
P/B Ratio0.4
Op. Cash Flow$1.3B
Industry P/E16.5

Technical Analysis

TrendBearish
RSI46.2
Support$18.99
Resistance$19.49
MA 20$19.17
MA 50$19.20
MA 200$20.82
MACDBullish
VolumeDecreasing
Fear & Greed Index87.96

Valuation

GradeUndervalued
TypeValue
Dividend Yield6.44%

Risk Assessment

Beta0.21
Volatility9.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.